Objectives: Epistaxis is the most frequent clinical manifestation of hereditary hemorrhagic telangiectasia (HHT). Several topical, systemic, and surgical treatments have been tried, but none have been completely effective. The aim of the present study is to evaluate whether a combined treatment sclerotherapy and topical therapy with propranolol 0.5% nasal formulation would reduce the epistaxis due to HHT and improve patient's quality of life.

Methods: An observational cross-sectional study was carried out. The primary outcome measure was frequency and severity of epistaxis as measured by the epistaxis severity score (ESS) at baseline (4 weeks before therapy) and at least 4 weeks after the treatment was implemented. Quality of life was analyzed using EuroQol-5D (EQ-5D) scale and visual analogue (VAS) scale before and after treatment.

Results: A total of 38 consecutive patients subjected to the combined treatment were evaluated (mean age: 57.2 years, standard deviation [SD] = 13.9; 60.5% women). The mean time of treatment was 37.1 weeks (SD = 14.9). Combined therapy significantly reduces frequency and severity of epistaxis, with an ESS improvement of 5 points from 6.9 ± 2.6 to 1.9 ± 1.3 (P < 0.05); however, the EQ-5D scale increased from 0.66 ± 0.27 to 0.93 ± 0.12 (P < 0.05). The difference in VAS means showed an increase from 44.6 ± 28.3 to 82.5 ± 12.5 (P < 0.05). The increases in quality of life are in line with the drop in ESS.

Conclusion: The study demonstrated that combined therapy (sclerotherapy and topical nasal propranolol) significantly reduced the epistaxis due to HHT and increased patients' quality of life.

Level Of Evidence: 2c Laryngoscope, 129:2216-2223, 2019.

Download full-text PDF

Source
http://dx.doi.org/10.1002/lary.27930DOI Listing

Publication Analysis

Top Keywords

sclerotherapy topical
8
combined treatment
8
frequency severity
8
severity epistaxis
8
epistaxis
5
topical nasal
4
nasal propranolol
4
propranolol effective
4
effective safe
4
therapy
4

Similar Publications

Article Synopsis
  • A 46-year-old man had purple-red, raised spots on his scrotum for 6 years that caused bleeding and distress, diagnosed as angiokeratoma of Fordyce.
  • He opted for cost-effective sclerotherapy using a 3% sodium tetradecyl sulfate solution after topical anesthesia.
  • After two sessions, his lesions completely resolved, showcasing a successful and minimally invasive treatment option for this condition.
View Article and Find Full Text PDF

Superficial Venous Disease-An Updated Review.

Ann Vasc Surg

August 2024

Interventional and Endovascular Cardiologist, Stern Cardiovascular Foundation, UT Health Science Center, Memphis, TN.

Article Synopsis
  • Superficial venous diseases (SVDs) primarily affect the lower extremities and can lead to serious issues like varicose veins, chronic venous insufficiency, and venous ulcers.
  • The review discusses the anatomy, risk factors (like age, race, and lifestyle), and the clinical classification of SVDs, emphasizing the Clinical-Etiology-Anatomy-Pathophysiology system.
  • Various imaging techniques (mainly duplex ultrasound), along with a range of treatment options from conservative methods like compression stockings to advanced interventional therapies, are presented for managing SVD effectively.
View Article and Find Full Text PDF

Loss of vision after topical injection of sclerosant is a rare and uncommon complication. We describe a case with vision loss following the facial injections of physician-compounded (PCP) foam sclerotherapy which was created by room air. A 3-year-old boy underwent injection of 5ml polidocanol foamed with room air to treat the venous malformation on the cheek near the left orbit.

View Article and Find Full Text PDF
Article Synopsis
  • Pyogenic granuloma (PG) is a reactive tissue disorder commonly found in the gums, particularly in females, characterized by a tumor-like mass that may bleed or ulcerate.
  • It can appear in various areas of the mouth and has two types: lobular capillary hemangioma variant and non-LCH variant.
  • Successful management often requires surgical excision and removal of local irritants to prevent recurrence, as shown in a case where a 28-year-old female had her recurrent swelling completely excised with no follow-up issues after nine months.
View Article and Find Full Text PDF

Seroma prevention with topical Abnobaviscum sclerotherapy following excision of giant cervical lipoma.

Arch Craniofac Surg

February 2023

Department of Plastic and Reconstructive Surgery, Chonnam National University Hospital, Chonnam National University Medical School, Gwangju, Korea.

Background: Lipomas are common benign tumors of mesenchymal origin that are composed of mature adipocytes. Giant lipomas have a diameter ≥ 10 cm in one or more dimensions or weigh at least 1,000 g. The surgical excision of a giant lipoma requires extensive dissection, increasing the risk of a seroma, which can cause surgical site complications such as wound infection and necrosis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!